Apr 26 |
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
|
Apr 25 |
Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Apr 24 |
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
|
Apr 18 |
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
|
Apr 11 |
3 Meme Stocks to Sell and Replace With Meme Coins
|
Apr 9 |
Allogene Therapeutics Announces Q2 Investor Conference Participation
|
Apr 7 |
We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully
|
Apr 1 |
Allogene Therapeutics: 2024 Platform Vision Sings Mid-Term Upside
|
Mar 16 |
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript
|
Mar 15 |
Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss
|